"A study from the University of Connecticut found that the anti-aging drug combination dasatinib+quercetin (D+Q) caused myelin damage in mice. The damage was more severe in younger mice and affected brain cells responsible for myelin production. The findings raise concerns about the safety of off-label use of these drugs for longevity."